2009 annual financial data
Galectin Therapeutics 2009 Operating margin
Galectin Therapeutics 2009 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -6,093,000 USD and net income was -7,462,000 USD.
Operating cash flow was -3,887,000 USD.
Get free Galectin Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- Not available
- Operating income
- -6,093,000 USD
- Net income
- -7,462,000 USD
- Operating cash flow
- -3,887,000 USD